Frequency of Urinary Tract Infections (UTIs) in Type 2 Diabetic Patients Taking Dapagliflozin

Cilnidipine decreases left atrial (LA) volume index superior than atenolol in the patients with hypertension

Efficacy of the use of mefenamic acid combined with standard medical care vs. standard medical care alone for the treatment of COVID‑19: A randomized double‑blind placebo‑controlled trial

Role of Esomeprazole in Early Preeclampsia: A Randomized Controlled Trial

Pioglitazone even at low dosage improves NAFLD in type 2 diabetes: clinical and pathophysiological insights from a subgroup of the TOSCA.IT randomized trial

Ondansetron for Shivering after Spinal Anesthesia in Cesarean Delivery: A Systematic Review and Meta-Analysis

Dapagliflozin does not increase risk of severe UTIs or acute liver injury

Omeprazole vs Famotidine for the prevention of gastroduodenal injury in high-risk users of low-dose aspirin: A randomized controlled trial

Effects of dapagliflozin on major adverse kidney and cardiovascular (CV) events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial